Retiro De Equipo (Recall) de Duracon Augments - Tibial Wedge Implants

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Stryker Australia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2015-RN-00971-1
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
    2015-10-02
  • País del evento
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Stryker has received two customer complaints regarding duracon tibial wedge implants that had punctured the packaging’s tyvek lid. in each case, the punctured tyvek lid was identified in the operating room and a new device was opened and used.In all stryker instructions for use (ifu) for the above referenced product, the end user is instructed to inspect the package for damage and, if present, to discard the device. operating room staff should conduct this packaging inspection for any breach in the outer and inner packaging. performing this inspection should mitigate this potential hazard. in the unlikely event the packaging is not inspected, there is a potential that a non-sterile implant will be implanted which may result in a post-operative infection.
  • Acción
    All affected products in the market have been recorded as being used. Stryker has decided that the implanting and treating physicians should be made aware of this issue to facilitate review of their patients for this issue as part of the normal post-operative course of treatment. Stryker recognises that the implanting and treating physicians are in the best position to exercise the necessary medical judgment for their patients . This action has been closed-out on 05/12/2016.

Device

  • Modelo / Serial
    Duracon Augments - Tibial Wedge ImplantsCatalogue Numbers:6630-6-105, 6630-6-110, 6630-6-125, 6630-6-130, 6630-6-150, 6630-6-155, 6630-6-170, 6630-6-175, 6630-6-205, 6630-6-210, 6630-6-225, 6630-6-230, 6630-6-250, 6630-6-255, 6630-6-270, 6630-6-275, 6630-6-305, 6630-6-310, 6630-6-325, 6630-6-330, 6630-6-350, 6630-6-355, 6630-6-370, 6630-6-375, 6630-6-405, 6630-6-410, 6630-6-425, 6630-6-430, 6630-6-450, 6630-6-455, 6630-6-470, 6630-6-475.Affected Lots: MultipleARTG Number: 242298
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Source
    DHTGA